alexa Recombinant Progranulin Prevents the Loss of Proteoglycan in Surgically Induced Osteoarthritis Model | Open Access Journals
ISSN: 2157-7099
Journal of Cytology & Histology
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Recombinant Progranulin Prevents the Loss of Proteoglycan in Surgically Induced Osteoarthritis Model

Chuanju Liu*

Department of Orthopaedic Surgery and Cell Biology, New York University School of Medicine, 301 East 17th Street, New York, USA

*Corresponding Author:
Chuanju Liu
Department of Orthopaedic Surgery and Cell Biology
New York University School of Medicine, 301 East 17th Street
New York, NY10003, USA
Tel: 212-598-6103
Fax: 212-598-6096
E-mail: [email protected]

Received Date: October 31, 2014; Accepted Date: October 31, 2014; Published Date: November 01, 2014

Citation: Liu C (2014) Recombinant Progranulin Prevents the Loss of Proteoglycan in Surgically Induced Osteoarthritis Model. J Cytol Histol 5:i104. doi: 10.4172/2157-7099.1000i104

Copyright: © 2014 Liu C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Cytology & Histology

Abstract

Osteoarthritis (OA) is a degenerative joint disease that affects more than 46 million people in the United States alone. Since mechanisms by which OA ensues are largely unknown, there are no therapeutic targets that effectively prevent and treat the disease. However, growth factors, cytokines and matrix-degrading enzymes are strongly implicated in initiating and aggravating OA lesions. Thus, a molecular understanding of these molecules will provide invaluable information toward the search for novel therapeutic targets for OA. Our genome-wide screen for novel, differentially expressed genes in OA led to the isolation of progranulin (PGRN) as a novel OA-associated growth factor [1]. In subsequent global screen for the binding proteins of PGRN, we found that PGRN bound to TNF Receptors (TNFR). In addition, PGRN blocks the binding of TNFα to TNFR and inhibits TNFα-induced ADAMTS cleavage of cartilage oligomeric matrix protein (COMP) [2]. These previous findings led us to determine whether recombinant PGRN prevents cartilage degradation in the progression of OA in vivo. For this purpose, we took advantage of PGRN knockout mice to generate anterior cruciate ligament (ACL) transection induced OA models which develop severe OA due to the deficiency of PGRN. Importantly, intra-articular injection of rPGRN growth factor significantly prevented the degeneration of cartilage in PGRN-deficient OA model. PGRN treated mice retained cartilage integrity and showed little or no degradation of cartilage matrix in comparison to highly degraded cartilage of non-treated mice (Figure).

cytology-histology-recombinant

Figure 1: Recombinant progranulin (rPGRN) reduces the loss of proteoglycanin surgically induced osteoarthritis (OA) model. Intra-articular injection ofrPGRN chondrogenic growth factor significantly prevented the degenerationof cartilage in PGRN-deficient OA model induced by anterior cruciate ligament(ACL) transection. PGRN treated mice retained cartilage integrity and showedlittle or no degradation of cartilage matrix in comparison to highly degradedcartilage of non-treated mice.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Article Usage

  • Total views: 11490
  • [From(publication date):
    November-2014 - Jun 29, 2017]
  • Breakdown by view type
  • HTML page views : 7744
  • PDF downloads :3746
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords